Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
23.63
+0.18 (0.75%)
May 1, 2024, 2:04 PM EDT - Market open
Bicycle Therapeutics Revenue
In the year 2023, Bicycle Therapeutics had annual revenue of $26.98M with 86.52% growth. Revenue in the quarter ending December 31, 2023 was $5.33M with 67.38% year-over-year growth.
Revenue (ttm)
$26.98M
Revenue Growth
+86.52%
P/S Ratio
37.14
Revenue / Employee
$94,986
Employees
284
Market Cap
1.01B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 26.98M | 12.51M | 86.52% |
Dec 31, 2022 | 14.46M | 2.77M | 23.65% |
Dec 31, 2021 | 11.70M | 1.31M | 12.58% |
Dec 31, 2020 | 10.39M | -3.41M | -24.72% |
Dec 31, 2019 | 13.80M | 6.67M | 93.40% |
Dec 31, 2018 | 7.14M | 5.08M | 246.41% |
Dec 31, 2017 | 2.06M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
MiMedx Group | 321.48M |
Innoviva | 310.46M |
Standard BioTools | 106.34M |
Cronos Group | 87.24M |
Arcutis Biotherapeutics | 59.61M |
Liquidia | 17.49M |
Abivax | 5.13M |
Perspective Therapeutics | 1.43M |
BCYC News
- 7 days ago - Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting - Business Wire
- 4 weeks ago - Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference - Business Wire
- 2 months ago - Bicycle Therapeutics to Present at the AACR Annual Meeting 2024 - Business Wire
- 2 months ago - Bicycle Therapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 3 months ago - Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference - Business Wire
- 4 months ago - Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day - Business Wire
- 5 months ago - Bicycle Therapeutics to Host R&D Day on December 14 - Business Wire